The unexpected turn: from tube to table with octreotide in persistent postoperative ileus: a case report
Authors:
Isaia Maddalena
, Alessandro ViganĂ²
, Tanja Fusi-Schmidhauser
Abstract
Background: Octreotide is used for symptom control in malignant bowel obstruction. Its role in non-malignant early postoperative mechanical small-bowel obstruction remains uncertain.
Case Presentation: A 62-year-old woman with severe pre-existing malnutrition underwent laparoscopic descending-colon resection and double-barrel colostomy for perforation with four-quadrant peritonitis. Histology showed ulcerative ischaemic colitis, with nonspecific findings on subsequent review. Serial computed tomography demonstrated mechanical small-bowel obstruction with transition points, distal decompression, and increasing dilatation. The course fluctuated, with intermittent stomal output. Further surgery was considered disproportionate to her frailty and prognosis, and treatment limitations were agreed with the patient and her representative. Continuous IV octreotide, used off-label at 0.9 mg/24 hours from 25 August, was added to multimodal conservative care. Nausea and colicky pain improved within approximately 12 hours. Sustained clinical improvement later permitted cessation of parenteral nutrition on 3 September and removal of the nasogastric tube on 4 September. She was discharged home on 11 September but was readmitted with recurrent obstruction on 28 September and subsequently received end-of-life care at home.
Conclusion: Octreotide initiation was temporally associated with symptom relief in this exceptional patient. Its contribution to restoration of bowel transit cannot be determined from this uncontrolled observation.
Keywords: Octreotide, small-bowel obstruction, postoperative complications, palliative care, case report.
Pubmed Style
Isaia Maddalena, Alessandro ViganĂ², Tanja Fusi-Schmidhauser. The unexpected turn: from tube to table with octreotide in persistent postoperative ileus: a case report. EJMCR. 2026; 06 (November 2026): 484-488. doi:10.24911/ejmcr.9-3145
Publication History
Received: September 13, 2026
Revised: October 21, 2026
Accepted: October 22, 2026
Published: November 06, 2026
Authors
Isaia Maddalena
Palliative and Supportive Care Clinic, Ospedale Regionale di Bellinzona e Valli, Ente Ospedaliero Cantonale, CH-6500 Bellinzona, Switzerland.
Alessandro ViganĂ²
Palliative and Supportive Care Clinic, Ospedale Regionale di Bellinzona e Valli, Ente Ospedaliero Cantonale, CH-6500 Bellinzona, Switzerland.
Tanja Fusi-Schmidhauser
Palliative and Supportive Care Clinic, Ospedale Regionale di Bellinzona e Valli, Ente Ospedaliero Cantonale, CH-6500 Bellinzona, Switzerland.